Melena Dawn Bellin MD
Pediatric Bone Metabolism Disorders
Assistant Professor, Pediatrics, University of Minnesota Medical School
Join to View Full Profile
2450 Riverside AveMinneapolis, MN 55454
Phone+1 612-365-6777
Fax+1 612-626-5262
Dr. Bellin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Pediatric Endocrinology, 2006 - 2009- University of MinnesotaResidency, Pediatrics, 2003 - 2006
- University of Minnesota Medical SchoolClass of 2003
Certifications & Licensure
MN State Medical License 2004 - 2025
WI State Medical License 2014 - 2015
American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant Start of enrollment: 2010 Aug 01
- Islet Transplant for Type 1 or Surgical Diabetes
- Closed Loop Insulin Pump Therapy After Islet Auto-Transplantation Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Long-Term Islet Graft Functional Assessment in More than 500 Patients Undergoing Total Pancreatectomy with Intraportal Islet Autotransplantation.Melena D Bellin, Anne Eaton, Karthik Ramanathan, Gregory Beilman, Elissa Downs
Journal of the American College of Surgeons. 2025-04-01 - Risk Factors and Mechanisms for Diabetes in Pancreatitis.María Graciela Parra Villasmil, Melena D Bellin
Gastroenterology Clinics of North America. 2025-03-01 - Recurrent Acute Pancreatitis: Many Faces(/Facets) of a Challenging Disease.Dhiraj Yadav, Nicholas J Zyromski, David C Whitcomb, Melena D Bellin, Gregory A Cote
Gastroenterology. 2025-02-25
Journal Articles
- Sitagliptin Treatment Increases GLP‐1 Without Improving Diabetes Outcomes After Total Pancreatectomy with Islet AutotransplantationKendall R McEachron, Melena D Bellin, Gregory J Beilman, American journal of transplantation
- Effect of Intrapancreatic Fat on Diabetes Outcomes After Total Pancreatectomy with Islet AutotransplantationSrinath Chinnakotla, Gregory J Beilman, Timothy L Pruett, Sarah J Schwarzenberg, Martin L Freeman, Melena D Bellin, Ty B Dunn, Journal of Diabetes
Press Mentions
Study Points to Obesity as Driver of Pancreatic CancerApril 16th, 2020
Grant Support
- Protein biomarkers to predict pain outcomes after total pancreatectomy with islet autotransplantUNIVERSITY OF MINNESOTA2023–2027
- Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT)UNIVERSITY OF MINNESOTA2021–2025
- Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT)UNIVERSITY OF MINNESOTA2021–2025
- University of Minnesota Clinical Center for the Study of Acute Pancreatitis and DiabetesUNIVERSITY OF MINNESOTA2020–2025
- University of Minnesota Clinical Center for the Study of Pancreatic DiseaseUNIVERSITY OF MINNESOTA2020–2025
- University of Minnesota Clinical Center for the Study of Pancreatic DiseaseUNIVERSITY OF MINNESOTA2020–2025
- University of Minnesota Clinical Center for the Study of Pancreatic DiseaseUNIVERSITY OF MINNESOTA2015–2025
- Pre-faculty Research Training in Pediatric EndocrinologyUNIVERSITY OF MINNESOTA2004–2025
- Sitagliptin Therapy To Improve Outcomes After Islet Autotransplantation.National Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
